Abbott Laboratories: A Dividend Aristocrat on Sale

Very few companies can match the consistent operating record of Abbott Laboratories (ABT). For more than 120 years, Abbott has demonstrated a durable and sustainable record as a growth company. As a broad-based healthcare company their diversified business strategy has enabled them to consistently generate top-tier performance versus their peers.For calendar 2009, Abbott was once again named to the Standard & Poor's 500 Dividend Aristocrats Index, a feat only 10% of S&P 500 companies have achieved. In February of 2010 Abbott increased their dividend by 11%. This marked the 37th consecutive year of rising dividends, and the 344th consecutive quarterly dividend. On June 11, 2010 they announced another dividend of $0.44, marking the 38th year of increase and the 346 consecutive dividend since 1924. Abbott's current dividend yield is 3.6%.... Read more

Older articles featuring ABT: